Background Cardiac resynchronisation therapy (CRT) is a well-established form of treatment
for patients with heart failure and cardiac dyssynchrony. There are two different types of CRT …

Objective To assess the cost-effectiveness of cardiac resynchronisation therapy (CRT) both
with CRT-P (biventricular pacemaker only) and with CRT-D (biventricular pacemaker with …

Objectives To assess the clinical effectiveness and cost-effectiveness of cardiac
resynchronisation therapy (CRT) for people with heart failure and evidence of dyssynchrony …

Aims Cardiac resynchronization therapy (CRT-P) is an effective treatment for patients with
heart failure and cardiac dyssynchrony with moderate or severe symptoms despite …

Abstract Background In Germany, CRT devices with defibrillator capability (CRT-D) have
become the predominant treatment strategy for patients with heart failure and cardiac …

Objectives: This study investigated the cost effectiveness of early cardiac resynchronization
therapy (CRT) implantation among patients with mild heart failure (HF). The differential cost …

Aim The aim of the study was to assess the incremental cost-effectiveness ratio (ICER) of
Cardiac Resynchronization Therapy in combination with an Implantable Cardioverter …

Objectives Cardiac resynchronization therapy with a biventricular pacemaker (CRT-P) is an
effective treatment for dyssynchronous heart failure (DHF). Adding an implantable …

Cardiac resynchronization therapy (CRT) is a treatment of proven efficacy for selected
patients with heart failure and associated conduction disturbances. The increasing financial …

Cost-effectiveness estimates can help optimize use of available financial resources and this
is especially relevant for implementation of cardiac resynchronization therapy (CRT), given …